0.000USD0.000盘前交易 08/03, 09:30 (美东)
关键数据
4.170今开
4.210最高
2.99M成交量
19.87市盈率 TTM
36.22市盈率动
--股息TTM
2.01%换手率
4.270昨收
3.973最低
7.76M成交额
14.50市盈率静
2.53市净率
0.00%股息率 TTM
10.60%ROA
7.99052周最高
1.17量比
42.42M净利润
148.93M总股本
0.2078每股收益TTM
1.47Beta
13.77%ROE
3.02552周最低
5.56%振幅
68.50%毛利率
601.99M总市值
2.00回报/风险
2.46%风险率
操作建议
MiMedx Group Inc当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在生物技术与医疗研究行业排名77/385位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价6.60。中期看,股价处于上升通道。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
MiMedx Group Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
MiMedx Group Inc简介
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
公司代码MDXG
公司MiMedx Group Inc
CEOCapper (Joseph H)
网址https://mimedx.com/
公司股东
常见问题
MiMedx Group Inc(MDXG)的当前股价是多少?
MiMedx Group Inc(MDXG)的当前股价是 4.13。
MiMedx Group Inc的股票代码是什么?
MiMedx Group Inc的股票代码是MDXG。
MiMedx Group Inc股票的52周最高点是多少?
MiMedx Group Inc股票的52周最高点是7.99。
MiMedx Group Inc股票的52周最低点是多少?
MiMedx Group Inc股票的52周最低点是3.02。
MiMedx Group Inc的市值是601.99M。
现在MiMedx Group Inc(MDXG)的股票是买入、持有还是卖出?
根据分析师评级,MiMedx Group Inc(MDXG)的总体评级为买入,目标价格为6.60。
MiMedx Group Inc(MDXG)股票的每股收益(EPS TTM)是多少
MiMedx Group Inc(MDXG)股票的每股收益(EPS TTM)是0.33。